Literature DB >> 34098924

Association of global sagittal spinal deformity with functional disability two years after total hip arthroplasty.

Yoshinori Okamoto1, Hitoshi Wakama2, Tomohiro Okayoshi2, Shuhei Otsuki2, Masashi Neo2.   

Abstract

BACKGROUND: The relationship between spinopelvic alignment and functional disability after total hip arthroplasty (THA) has not been fully elucidated despite the growing recognition of its importance on patient-reported outcome measures. Therefore, our aim was to assess the effect of global sagittal spinal deformity on post-operative disability.
METHODS: This analysis was based on 208 cases of THA, with functional disability measured at a follow-up of 2 years. The Hip Disability and Osteoarthritis Outcome Score-Joint Replacement (HOOS-JR), ranging from a scale of 0 (complete joint disability) to 100 (perfect joint health), was used to divide eligible patients into two groups, namely with and without disability, using a score of 70 as the cut-off. The following factors were compared between the two groups using multivariate analysis: age, sex, body height, body mass index, spinopelvic parameters, and surgeon experience. To identify the cut-off value of the parameters for predicting disability (HOOS-JR < 70/100), we used the receiver-operating characteristic curve.
RESULTS: The disability (30 hips) and control (178 hips) groups showed a significant difference in pre-operative body height (p = 0.020), T1 pelvic angle divided by pelvic incidence (T1PA/PI; p = 0.018), PI minus lumbar lordosis (p = 0.027), post-operative HOOS-JR (p = 0.010), patient satisfaction (p = 0.033), and the modified Harris Hip Score (p = 0.038). On multivariate analysis, the following factors were associated with persistent disability: T1PA/PI > 0.2 (odds ratio [OR], 2.11; 95% confidence interval [CI], 1.19-4.14; p <  0.001) and height < 148 cm equivalent to legal standards as short stature (OR, 1.26; 95% CI, 1.09-1.48; p = 0.011). The cut-off value of pre-operative T1PA/PI was > 0.19, with a sensitivity of 95% and specificity of 85%. Post-operative satisfaction (p <  0.001), HOOS-JR (p = 0.023), and EuroQol 5-Dimension (p = 0.041) differed between the two groups when the pre-operative cut-off value was chosen as 0.2.
CONCLUSIONS: A T1PA/PI > 0.2 was associated with greater disability after THA. Clinicians should be aware that patient-related factors, including global spinal deformities, particularly in patients with a short stature, can influence THA outcomes at 2 years postoperatively.

Entities:  

Keywords:  Disability; Global sagittal deformity; Spinopelvic alignment; T1 pelvic angle, Total hip arthroplasty

Year:  2021        PMID: 34098924     DOI: 10.1186/s12891-021-04415-1

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  17 in total

1.  Pelvic incidence: a fundamental pelvic parameter for three-dimensional regulation of spinal sagittal curves.

Authors:  J Legaye; G Duval-Beaupère; J Hecquet; C Marty
Journal:  Eur Spine J       Date:  1998       Impact factor: 3.134

2.  Impact of coexistent lumbar spine disorders on clinical outcomes and physician charges associated with total hip arthroplasty.

Authors:  Heidi Prather; Linda R Van Dillen; Steven M Kymes; Melissa A Armbrecht; Dustin Stwalley; John C Clohisy
Journal:  Spine J       Date:  2012-01-09       Impact factor: 4.166

3.  Vertebral fracture assessment using a semiquantitative technique.

Authors:  H K Genant; C Y Wu; C van Kuijk; M C Nevitt
Journal:  J Bone Miner Res       Date:  1993-09       Impact factor: 6.741

4.  The spino-pelvic ratio: a novel global sagittal parameter associated with clinical outcomes in adult spinal deformity patients.

Authors:  Wesley M Durand; Alan H Daniels; David K Hamilton; Peter Passias; Han Jo Kim; Themistocles Protopsaltis; Virginie LaFage; Justin S Smith; Christopher Shaffrey; Munish Gupta; Michael P Kelly; Eric Klineberg; Frank Schwab; Doug Burton; Shay Bess; Christopher Ames; Robert Hart
Journal:  Eur Spine J       Date:  2020-06-01       Impact factor: 3.134

5.  Acetabular Anteversion Changes Due to Spinal Deformity Correction: Bridging the Gap Between Hip and Spine Surgeons.

Authors:  Aaron J Buckland; Jonathan Vigdorchik; Frank J Schwab; Thomas J Errico; Renaud Lafage; Christopher Ames; Shay Bess; Justin Smith; Gregory M Mundis; Virginie Lafage
Journal:  J Bone Joint Surg Am       Date:  2015-12-02       Impact factor: 5.284

6.  2018 Frank Stinchfield Award: Spinopelvic Hypermobility Is Associated With an Inferior Outcome After THA: Examining the Effect of Spinal Arthrodesis.

Authors:  George Grammatopoulos; Wade Gofton; Zaid Jibri; Matthew Coyle; Johanna Dobransky; Cheryl Kreviazuk; Paul R Kim; Paul E Beaulé
Journal:  Clin Orthop Relat Res       Date:  2019-02       Impact factor: 4.176

7.  The John Charnley Award: Redefining the Natural History of Osteoarthritis in Patients With Hip Dysplasia and Impingement.

Authors:  Cody C Wyles; Mark J Heidenreich; Jack Jeng; Dirk R Larson; Robert T Trousdale; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2017-02       Impact factor: 4.176

8.  Worse patient-reported outcome after lateral approach than after anterior and posterolateral approach in primary hip arthroplasty. A cross-sectional questionnaire study of 1,476 patients 1-3 years after surgery.

Authors:  Einar Amlie; Leif I Havelin; Ove Furnes; Valborg Baste; Lars Nordsletten; Oystein Hovik; Sigbjorn Dimmen
Journal:  Acta Orthop       Date:  2014-06-23       Impact factor: 3.717

9.  John Charnley Award: Preoperative Patient-reported Outcome Measures Predict Clinically Meaningful Improvement in Function After THA.

Authors:  Jonathan L Berliner; Dane J Brodke; Vanessa Chan; Nelson F SooHoo; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2016-02       Impact factor: 4.176

10.  Does surgeon experience affect patient-reported outcomes 1 year after primary total hip arthroplasty?

Authors:  Per Jolbäck; Ola Rolfson; Maziar Mohaddes; Szilárd Nemes; Johan Kärrholm; Göran Garellick; Hans Lindahl
Journal:  Acta Orthop       Date:  2018-03-06       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.